Rifaximin for the prevention of spontaneous bacterial peritonitis

doi:10.3748/wjg.v18.i14.1700

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3859)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

355

HTML

3235

Figures (1-1)

138

Tables (1-1)

131

Sum=3859

Apr 14, 2012 (publication date) through Apr 22, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letters To The Editor

World J Gastroenterol. Apr 14, 2012; 18(14): 1700-1702
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1700

Open in New Tab Full Size Figure Download Figure

Figure 1 Individual changes in ascitic fluid white blood cell (A), neutrophil count (B) and proportion of neutrophils (C), and plasma endotoxin levels (D) after administration of rifaximin for 4 wk.

Citation: Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin for the prevention of spontaneous bacterial peritonitis. World J Gastroenterol 2012; 18(14): 1700-1702
URL: https://www.wjgnet.com/1007-9327/full/v18/i14/1700.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i14.1700